1. |
張海波, 侯曉彤, 郭應強. 心尖途徑經導管主動脈瓣置換術圍術期管理規范專家建議. 中國胸心血管外科臨床雜志, 2023, 30(7): 927-935.Zhang HB, Hou XT, Guo YQ. Expert recommendations for standardized perioperative management after transapical transcatheter aortic valve implantation. Chin J Clin Thorac Cardiovasc Surg, 2023, 30(7): 927-935.
|
2. |
中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 中國經導管主動脈瓣置換術臨床路徑專家共識(2021版). 中國介入心臟病學雜志, 2022, 30(1): 7-16.Structural Heart Disease Professional Committee of Cardiovascular Physicians Branch, Chinese Medical Doctor Association. Chinese transcatheter aortic valve replacement clinical pathway expert consensus (2021 edition). Chin J Intervent Cardiol, 2022, 30(1): 7-16.
|
3. |
劉毅, 鄧麗, 曹勇, 等. 經導管主動脈瓣膜植入術的臨床治療及應用進展. 心肺血管病雜志, 2021, 40(11): 1175-1178.Liu Y, Deng L, Cao Y, et al. Clinical treatment and application progress of transcatheter aortic valve implantation. J Cardiovasc Pulm Dis, 2021, 40(11): 1175-1178.
|
4. |
周達新, 潘文志, 吳永健, 等. 經導管主動脈瓣置換術中國專家共識(2020更新版). 中國介入心臟病學雜志, 2020, 28(6): 301-309.Zhou DX, Pan WZ, Wu YJ, et al. Chinese expert consensus on transcatheter aortic valve replacement (2020 update). Chin J Intervent Cardiol, 2020, 28(6): 301-309.
|
5. |
Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: Meta-analysis and systematic review of literature. J Am Coll Cardiol, 2013, 61(15): 1585-1595.
|
6. |
陳思毅, 劉健迪, 劉航宇, 等. 經導管主動脈瓣置換術后發生瓣周漏患者的臨床特征及危險因素分析. 中國介入心臟病學雜志, 2023, 31(4): 273-279.Chen SY, Liu JD, Liu HY, et al. Analysis of clinical characteristics and risk factors in patients with paravalvular leakage after transcatheter aortic valve replacement. Chin J Intervent Cardiol, 2023, 31(4): 273-279.
|
7. |
Webb JG, Blanke P, Meier D, et al. TAVI in 2022: Remaining issues and future direction. Arch Cardiovasc Dis, 2022, 115(4): 235-242.
|
8. |
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med, 2019, 380(18): 1695-1705.
|
9. |
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
|
10. |
Tsoi M, Tandon K, Zimetbaum PJ, et al. Conduction disturbances and permanent pacemaker implantation after transcatheter aortic valve replacement: Predictors and prevention. Cardiol Rev, 2022, 30(4): 179-187.
|
11. |
Zhang X, Liang C, Zha L, et al. Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty?): A retrospective cohort study. BMC Cardiovasc Disord, 2024, 24(1): 77.
|
12. |
Takagi H, Hari Y, Nakashima K, et al. Mortality after transcatheter versus surgical aortic valve replacement: An updated meta-analysis of randomised trials. Neth Heart J, 2020, 28(6): 320-333.
|
13. |
Thonghong T, De Backer O, S?ndergaard L. Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease. Open Heart, 2018, 5(1): e000753.
|
14. |
Faroux L, Villecourt A, Metz D. The management of coronary artery disease in TAVR patients. J Clin Med, 2023, 12(22): 7126.
|
15. |
Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review. J Am Coll Cardiol, 2019, 74(3): 362-372.
|
16. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
|
17. |
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Kardiol Pol, 2018, 76(12): 1585-1664.
|